Investigational New Drug (IND) Programs
Source: Charles River
Learn through our years of IND research experience, unique range of services and best-in-class expertise how we can help you successfully initiate and complete your IND-enabling program.
Access the Source℠
- IND Gantt charts for large and small molecules
- Recorded webinar on planning your IND
With our ongoing efforts to improve upon our internal processes and continued focus on scientific excellence and guidance, we are pleased to offer a highly cost-effective IND program for our clients.
We offer a fully compiled, audited draft report at 10 weeks post-necropsy for studies up to and including 13 weeks of treatment across all Charles River preclinical facilities.